Publications by authors named "J Rua"
Objective: To assess the impact of concomitant systemic lupus erythematosus (SLE) on the clinicopathological manifestations of thrombotic antiphospholipid syndrome (APS).
Methods: This single-centre, retrospective study compared clinical and antiphospholipid antibody (aPL) data from 118 patients, 58 with SLE-associated APS (SLE-APS), and 60 with primary APS.
Results: Median follow-up was 13.
Chicken meat and its derivatives are easily alterable. They are a nutritionally healthy food, and their consumption has seen a remarkable increase worldwide in recent years. At the same time, consumer demand for the use of natural products to control microbial growth is increasing.
View Article and Find Full Text PDFRecommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review.
Clin Transl Oncol
April 2024
Article Synopsis
- The study focuses on the evolving treatment strategies for liver metastases from colon cancer, highlighting the role of Yttrium-90 Radioembolization (Y-90 TARE) as a viable option for patients with unresectable liver metastases.
- A multidisciplinary committee of experts conducted a thorough literature review to create recommendations on the use of Y-90 TARE, addressing criteria like patient selection, treatment indications, and potential contraindications.
- The review provides a detailed framework for implementing Y-90 TARE, covering essential areas from initial patient evaluation to post-treatment follow-up, ensuring comprehensive management of the treatment process.
Introduction: We present a clinical case of a 45-year-old man with recurrent deep vein thrombosis (DVT) and multiple hospital admissions due to severe infectious conditions. A newfound hypoalbuminemia raised the suspicion of a protein-losing condition, with an upper endoscopy revealing lesions at the D2 level compatible with coeliac sprue and HLA typing positive for both DQ-2 and DQ-8.
Methods: A gluten free diet was started and apixaban was suspended.
Objectives: This review addresses the question of what happens long-term to those systemic lupus erythematosus (SLE) patients who develop gangrene. It also seeks to find common clinical and serological features, risk factors and triggers and how best to manage this challenging complication.
Methods: We reviewed 850 patients with SLE attending a UK tertiary referral center, followed up over 44 years, assessing their demographics, clinical and serological features, treatment in the acute phase, their long-term outcome and long-term management.